申请人:The Procter & Gamble Company
公开号:US05672598A1
公开(公告)日:1997-09-30
The present invention relates to compounds that exhibit inhibitory activity against matrix metalloproteases ("MMPs"). Because MMPs are known to play a role in tissue degradation, the compounds of the present invention may be useful in preventing or treating diseases associated with excess MMP activity. In particular, the compounds have a structure according to Formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are various substituents as described in the specification; and Q is an alkyl chain, an alkenyl chain, a heteroalkyl chain, or a heteroalkenyl chain, wherein said chain has 2, 3, or 4 chain atoms and is unsubstituted or substituted with one or more alkyl moieties; or a pharmaceutically-acceptable salt, or biohydrolyzable alkoxyamide, acyloxyamide, or imide thereof. Preferred are those compounds where Q is an alkyl chain having 2, 3 or 4 chain atoms. The invention also relates to pharmaceutical compositions comprising these compounds, and methods for preventing or treating diseases associated with unwanted MMP activity using the compounds and compositions.
本发明涉及一种对基质金属蛋白酶(“MMPs”)具有抑制活性的化合物。由于MMPs已知在组织降解中发挥作用,本发明的化合物可能有助于预防或治疗与过量MMP活性相关的疾病。特别地,该化合物具有如下结构公式(I):##STR1## 其中R.sup.1、R.sup.2、R.sup.3和R.sup.4是如说明书中所述的各种取代基;Q是烷基链、烯基链、杂原子烷基链或杂原子烯基链,其中该链具有2、3或4个链原子,未取代或取代有一个或多个烷基基团;或其药学上可接受的盐、生物水解的烷氧酰胺、酰氧酰胺或酰亚胺。优选的是Q是具有2、3或4个链原子的烷基链。本发明还涉及包含这些化合物的药物组合物,以及使用这些化合物和组合物预防或治疗与不需要的MMP活性相关的疾病的方法。